Abstract
The occurrence of pharmaceutical products in the aquatic environment has increased the concern over the potential impact to the aquatic biota. In particular broad activity spectrum antibiotics, as fluoroquinolones (FQ), which possibly contribute to proliferation of antibiotic resistant bacteria. Due to the concern to the presence, persistence and fate of these products in environment, it …